Clinical Trials Browser

HTLV-I Infections × Nivolumab × Lymphoid × Clear all

NCT02631746 2025-03-14

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Phase 2 Completed

3 enrolled 8 charts

LymphoidOther hematologic neoplasm

Lymphoma, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma